Retatrutide News Update: 28% Weight Loss, But the Real Number Is the Dropout Rate I talk about the exciting news of retatrutide achieving 28% weight loss at 12 milligrams, but highlight that nearly half of participants dropped out due to nausea and vomiting. I emphasize that the goal of GLP-1 therapy is sustainable dosing to manage food noise without severe GI side effects, sharing my own experience with Zepbound where I had to reduce my dose to avoid nausea. The key takeaway is that you don't need the highest dose for effective results. #learnontiktokcontest #stemtiktokcontest #update #glp1 #glp1community